Back to Search
JAMES SALATA, MD
MD
Otolaryngology Physician
NPI: 1871553446IndividualAccepts Medicare
Specialties, Licenses & Credentials
Otolaryngology PhysicianPrimary
Otolaryngology
Code: 207Y00000X
0101055466(VA)
CMS Specialties
PrimaryOTOLARYNGOLOGY
Education
PERELMAN SCHOOL OF MED AT THE UNIVERSITY OF PENNSYLVANIA
Class of 1991
Research & Publications (20)
Removal of Plasmodium falciparum-infected red blood cells from whole blood by leukoreduction filters.
PMID 19389214·Transfusion·2009
7-preclinical
The hERG channel and risk of drug-acquired cardiac arrhythmia: an overview.
PMID 18782006·Curr Top Med Chem·2008
6-review
Modeling of the adrenergic response of the human IKs current (hKCNQ1/hKCNE1) stably expressed in HEK-293 cells.
PMID 18757482·Am J Physiol Heart Circ Physiol·2008
8-other
Improved throughput of PatchXpress hERG assay using intracellular potassium fluoride.
PMID 18471077·Assay Drug Dev Technol·2008
7-preclinical
Inactivation of Leishmania donovani infantum and Trypanosoma cruzi in red cell suspensions with thiazole orange.
PMID 18422841·Transfusion·2008
7-preclinical
Neutrophil priming, caused by cell membranes and microvesicles in packed red blood cell units, is abrogated by leukocyte depletion at collection.
PMID 18343726·Transfus Apher Sci·2008
8-other
Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light.
PMID 17950672·Transfus Apher Sci·2007
7-preclinical
Application of PatchXpress planar patch clamp technology to the screening of new drug candidates for cardiac KCNQ1/KCNE1 (I Ks) activity.
PMID 17939752·Assay Drug Dev Technol·2007
7-preclinical
Kinesin spindle protein (KSP) inhibitors. Part 7: Design and synthesis of 3,3-disubstituted dihydropyrazolobenzoxazines as potent inhibitors of the mitotic kinesin KSP.
PMID 17804233·Bioorg Med Chem Lett·2007
7-preclinical
Kinesin spindle protein (KSP) inhibitors. Part 6: Design and synthesis of 3,5-diaryl-4,5-dihydropyrazole amides as potent inhibitors of the mitotic kinesin KSP.
PMID 17761419·Bioorg Med Chem Lett·2007
8-other
Photoinactivation of Trypanosoma cruzi in red cell suspensions with thiopyrylium.
PMID 17698414·Transfus Apher Sci·2007
7-preclinical
Inactivation of Orientia tsutsugamushi in red blood cells, plasma, and platelets with riboflavin and light, as demonstrated in an animal model.
PMID 17302769·Transfusion·2007
7-preclinical
Photoinactivation of Leishmania donovani infantum in red cell suspensions by a flexible thiopyrylium sensitizer.
PMID 16907880·Vox Sang·2006
7-preclinical
In vitro variables of red blood cell components collected by apheresis and frozen 6 and 14 days after collection.
PMID 16836565·Transfusion·2006
8-other
Leukodepletion filters reduce Leishmania in blood products when used at collection or at the bedside.
PMID 16734805·Transfusion·2006
7-preclinical
Novel, potent inhibitors of human Kv1.5 K+ channels and ultrarapidly activating delayed rectifier potassium current.
PMID 16522807·J Pharmacol Exp Ther·2006
7-preclinical
Flunarizine is a highly potent inhibitor of cardiac hERG potassium current.
PMID 16495758·J Cardiovasc Pharmacol·2006
7-preclinical
Pathogen inactivation of Leishmania donovani infantum in plasma and platelet concentrates using riboflavin and ultraviolet light.
PMID 16430665·Vox Sang·2006
7-preclinical
White particulate matter found in blood collection bags consist of platelets and leukocytes.
PMID 15225233·Transfusion·2004
8-other
Functional expression of L- and T-type Ca2+ channels in murine HL-1 cells.
PMID 14734053·J Mol Cell Cardiol·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1870 AMHERST ST STE 2B
WINCHESTER, VA 22601 - Phone
- (540) 536-2790
Quick Facts
- NPI
- 1871553446
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 35
- Publications
- 20
Are you this provider?
Claim Your Profile